Work

Interstitial Lung Disease as a Late Occurrence in Ocrelizumab-Treated Patients With Multiple Sclerosis

Year: 2026

Type: article

Abstract: This case series describes 6 cases of interstitial lung disease among patients with multiple sclerosis receiving long-term treatment with ocrelizumab.

Source: JAMA Neurology

DOI: 10.1001/jamaneurol.2026.0548

Authors: Anna E. Zurawska, Anne H. Cross, Katarzyna Rzeszutek, Agnieszka Rogozińska-Zawiślak, Krzysztof W. Selmaj

Institutions: University of Warmia and Mazury in Olsztyn, Washington University in St. Louis

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7150948123

FWCI: 18.22

Cites: 6

Cited by: 4

Related to: